SILENCE THERAP. SP.ADR/1 Working Capital to Net Assets Ratio
SILENCE THERAP. SP.ADR/1 working capital to net assets ratio. SILENCE THERAP. SP.ADR/1 (XRP2) has a Working Capital to Net Assets ratio of 168.6% as of December 2025. Working capital of €105.05 Million (current assets of €118.66 Million minus current liabilities of €13.61 Million) is measured against net assets of €62.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check SILENCE THERAP. SP.ADR/1 (XRP2) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SILENCE THERAP. SP.ADR/1 (2021–2025)
Working capital to net assets ratio of SILENCE THERAP. SP.ADR/1 from 2021 to 2025. This chart shows how SILENCE THERAP. SP.ADR/1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 168.6%, reflecting working capital of €105.05 Million against net assets of €62.30 Million EUR. See XRP2 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
SILENCE THERAP. SP.ADR/1 Working Capital to Net Assets Ratio by Year (2021–2025)
SILENCE THERAP. SP.ADR/1 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SILENCE THERAP. SP.ADR/1 total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 168.6% | €105.05 Million | €62.30 Million | €118.66 Million | €13.61 Million | ▲ +41.4 pp |
| 2024 | 127.2% | €170.54 Million | €134.02 Million | €187.37 Million | €16.82 Million | ▼ -240.2 pp |
| 2023 | 367.5% | €80.81 Million | €21.99 Million | €103.15 Million | €22.34 Million | ▲ +28.8 pp |
| 2022 | 338.6% | €90.45 Million | €26.71 Million | €117.01 Million | €26.56 Million | ▼ -496.1 pp |
| 2021 | 834.7% | €96.05 Million | €11.51 Million | €116.52 Million | €20.47 Million | — |